417 related articles for article (PubMed ID: 22378194)
1. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
2. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.
Chen T; He S; Zhang Z; Gao W; Yu L; Tan Y
Exp Cell Res; 2014 Aug; 326(2):326-35. PubMed ID: 24803390
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes regulated by nanog which is involved in ES cells pluripotency and early differentiation.
Liu N; Feng X; Fang Z; Ma F; Lu S; Lu M; Han Z
J Cell Biochem; 2008 Aug; 104(6):2348-62. PubMed ID: 18442017
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide gain-of-function screen identifies novel regulators of pluripotency.
Abujarour R; Efe J; Ding S
Stem Cells; 2010 Sep; 28(9):1487-97. PubMed ID: 20629179
[TBL] [Abstract][Full Text] [Related]
5. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
Shi G; Gao F; Jin Y
J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
[TBL] [Abstract][Full Text] [Related]
6. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3.
Torres J; Watt FM
Nat Cell Biol; 2008 Feb; 10(2):194-201. PubMed ID: 18223644
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
8. Nanog and transcriptional networks in embryonic stem cell pluripotency.
Pan G; Thomson JA
Cell Res; 2007 Jan; 17(1):42-9. PubMed ID: 17211451
[TBL] [Abstract][Full Text] [Related]
9. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.
Cinelli P; Casanova EA; Uhlig S; Lochmatter P; Matsuda T; Yokota T; Rülicke T; Ledermann B; Bürki K
BMC Dev Biol; 2008 May; 8():57. PubMed ID: 18500982
[TBL] [Abstract][Full Text] [Related]
11. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog.
Bourillot PY; Aksoy I; Schreiber V; Wianny F; Schulz H; Hummel O; Hubner N; Savatier P
Stem Cells; 2009 Aug; 27(8):1760-71. PubMed ID: 19544440
[TBL] [Abstract][Full Text] [Related]
12. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells.
Niwa H; Ogawa K; Shimosato D; Adachi K
Nature; 2009 Jul; 460(7251):118-22. PubMed ID: 19571885
[TBL] [Abstract][Full Text] [Related]
13. Hesx1 enhances pluripotency by working downstream of multiple pluripotency-associated signaling pathways.
Li WZ; Wang ZW; Chen LL; Xue HN; Chen X; Guo ZK; Zhang Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):936-42. PubMed ID: 26188092
[TBL] [Abstract][Full Text] [Related]
14. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
[TBL] [Abstract][Full Text] [Related]
15. Exogenous Nanog alleviates but is insufficient to reverse embryonic stem cells differentiation induced by PI3K signaling inhibition.
Liu N; Lu M; Feng XM; Ma FX; Fang ZH; Tian XM; Ren Q; Zhang L; Liu B; Huang PP; Liu L; Han ZC
J Cell Biochem; 2009 Apr; 106(6):1041-7. PubMed ID: 19229869
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state.
Lanner F; Lee KL; Sohl M; Holmborn K; Yang H; Wilbertz J; Poellinger L; Rossant J; Farnebo F
Stem Cells; 2010 Feb; 28(2):191-200. PubMed ID: 19937756
[TBL] [Abstract][Full Text] [Related]
17. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
Greber B; Lehrach H; Adjaye J
BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
[TBL] [Abstract][Full Text] [Related]
18. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
[TBL] [Abstract][Full Text] [Related]
19. Cell-permeant recombinant Nanog protein promotes pluripotency by inhibiting endodermal specification.
Peitz M; Münst B; Thummer RP; Helfen M; Edenhofer F
Stem Cell Res; 2014 May; 12(3):680-9. PubMed ID: 24681518
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism of cardiac differentiation in P19 embryonal carcinoma cells regulated by Foxa2].
Zhu H; Zhang Z; Liu Y; Chen Y; Tan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):356-64. PubMed ID: 23645235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
